Carlos V Paya is Director of Vaxcyte, Inc.. Currently has a direct ownership of 1,550 shares of PCVX, which is worth approximately $139,283. The most recent transaction as insider was on Dec 06, 2024, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.55K
61.73% 3M change
38.0% 12M change
Total Value Held $139,283

Carlos V Paya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2024
SELL
Bona fide gift
-
2,500 Reduced 61.73%
1,550 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
1,550 Added 27.68%
4,050 Common Stock
Nov 09 2023
SELL
Bona fide gift
-
3,125 Reduced 55.56%
2,500 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
2,500 Added 30.77%
5,625 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
3,125 Added 50.0%
3,125 Common Stock

Also insider at

MNKPF
Mallinckrodt plc Healthcare
LAB
STANDARD BIOTOOLS INC. Healthcare
CVP

Carlos V Paya

Director
San Carlos, CA

Track Institutional and Insider Activities on PCVX

Follow Vaxcyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX